Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14322279 | 1.00 | GAA (0.48) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL367278 | 1.00 | GAA (0.48) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL29369734 | 1.00 | GAA (0.48) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL11913917 | 0.87 | GAA (0.46) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL14323026 | 0.87 | GAA (0.46) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL14330214 | 0.85 | GAA (0.47) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL14324043 | 0.85 | GAA (0.47) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL14324042 | 0.85 | GAA (0.47) | GAAALDH1A1MEN1MAPTKMT2A | |
| Eucalyptol SCHEMBL28249441 | 0.85 | GAA (0.40) | GAAALDH1A1MEN1MAPTKMT2A | |
| SCHEMBL118412 | 0.85 | PPARD (0.60) | ALOX5PTPN1PPARGPPARDNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037843-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-08 | — | — | US | claimed |
| EP-2723841-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2017-01-04 | — | — | EP | claimed |
| US-20160186093-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-06-30 | — | — | US | claimed |
| US-9309487-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2016-04-12 | — | — | US | claimed |
| US-20140378360-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2014-12-25 | — | — | US | claimed |
| EP-2723841-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2014-04-30 | — | — | EP | claimed |
| US-20120329696-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2012-12-27 | — | — | US | claimed |
| WO-2012177357-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2012-12-27 | — | — | WO | claimed |
| US-20180037843-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-08 | — | — | US | disclosed |
| US-9822327-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-21 | — | — | US | disclosed |
| US-20160186093-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-06-30 | — | — | US | disclosed |
| US-9309487-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2016-04-12 | — | — | US | disclosed |
| US-20140378360-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2014-12-25 | — | — | US | disclosed |
| US-8912350-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2014-12-16 | — | — | US | disclosed |
| US-20120329696-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2012-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037843-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | GAA 2528/4885ALDH1A1 1292/4885MEN1 3884/4885 |
| US-20120329696-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | GAA 2528/4885ALDH1A1 1292/4885MEN1 3884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.